CD4 and neoplasm: TMZ significantly decreased the Treg/CD4+ T cell proportion when given at very low doses but not at high standard doses.Treg depletion alone, detected in LDM TMZ-treated rats, was not sufficient to significantly inhibit tumor progression, compared to control.